Invesco Nasdaq Biotechnology ETF
IBBQ----
Invesco Nasdaq Biotechnology ETF (IBBQ)
Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. The...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- StockTitan · 10 hours ago
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer | MRK Stock News
- PUBT · 22 hours ago
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancer
- PR Newswire · 1 day ago, 06:00 PM
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS
- prnewswire · 1 day ago, 03:28 PM
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
- Tip Ranks · 21 hours ago
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price Target
- MorningStar · 1 day ago, 03:14 PM
REGN Breaking News: Regeneron Inc. Sued for Securities Fraud after Revealing Failed Phase III Clinical Trial Resulting in 10% Stock Drop – Investors Notified to Contact BFA Law
